Commentary on Post, et al. Ultra-early tranexamic acid after subarachnoid hemorrhage: A randomized controlled trial. Lancet 2021

BACKGROUND: Tranexamic acid (TA) administration in aneurysmal subarachnoid hemorrhage (SAH) within the first 24 hours may reduce the incidence of early aneurysmal rebleeding. However, this is also the potential for an increased risk of delayed cerebral ischemia if TA is administered for more than 72...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Benjamin W. Y., Fukuda, Hitoshi, Tsang, Anderson C. O., Langer, David J., Miyawaki, Satoru, Koyanagi, Masaomi, Lui, Matthew Wai-Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088487/
https://www.ncbi.nlm.nih.gov/pubmed/33948326
http://dx.doi.org/10.25259/SNI_242_2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088487/
https://www.ncbi.nlm.nih.gov/pubmed/33948326
http://dx.doi.org/10.25259/SNI_242_2021

Ejemplares similares